A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression. [electronic resource]
Producer: 20060130Description: 1103-15 p. digitalISSN:- 1074-5521
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle
- Cell Line, Tumor
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Drug Screening Assays, Antitumor
- HCT116 Cells
- Humans
- Intracellular Signaling Peptides and Proteins -- classification
- Proteome -- drug effects
- Pyrimidines -- classification
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.